Skip to main content
Cipla Ltd. logo

Cipla Ltd. — Investor Relations & Filings

Ticker · CIPLA ISIN · INE059A01026 LEI · 335800KMJJYEDDK82Q34 BSE.NS Manufacturing
Open in API
Filings indexed 2,616 across all filing types
Latest filing 2020-07-21 Regulatory Filings
Country IN India
Listing BSE.NS CIPLA

About Cipla Ltd.

https://www.cipla.com/

Cipla Ltd. is a global pharmaceutical company focused on the development, manufacturing, and marketing of a wide range of generic and branded medicines. The company maintains a diverse portfolio of over 1,500 products across various therapeutic areas, including respiratory, anti-retroviral, urology, cardiology, anti-infective, and central nervous system treatments. It is recognized for its leadership in respiratory care and its historical role in making HIV/AIDS treatment affordable through the introduction of low-cost antiretroviral drugs. Operating with a strong emphasis on research and development, the firm utilizes advanced technology to produce complex generics and drug delivery systems. Its global footprint spans multiple continents, serving healthcare providers and patients in numerous international markets through a robust supply chain and manufacturing infrastructure.

Recent filings

Filing Released Lang Actions
Restructuring
Regulatory Filings Classification · 95% confidence The document is a disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It announces the amalgamation of two step-down wholly owned subsidiaries of Cipla Limited. The content focuses on notifying the stock exchanges and the public about this corporate restructuring event, providing details about the companies involved, reasons for restructuring, and effects on shareholding. There are no financial statements, earnings data, or detailed management analysis. The document is a regulatory announcement about a corporate event rather than a full report or financial filing. Therefore, it fits best under Regulatory Filings (RNS). The document length is 3584 characters, which is relatively short and consistent with an announcement rather than a full report.
2020-07-21 English
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015,and as per the Certificate of Amalgamation issued by the Registrar of Companies, ....
Regulatory Filings
2020-07-21 English
Updates
Legal Proceedings Report Classification · 95% confidence The document is a formal announcement from Cipla Limited regarding the settlement of pending litigation with Amgen Inc. It details the resolution of a civil action related to generic cinacalcet hydrochloride tablets and provides information about the legal status and product indications. The document is short (2200 characters) and serves as an update on a legal proceeding rather than a full legal report or financial document. It does not contain financial data, audit information, or detailed management discussion. Therefore, it fits best under the category of Legal Proceedings Report (LTR).
2020-07-20 English
The civil action filed by Cipla Limited and Cipla USA Inc, wholly owned step-down subsidiary of Cipla Limited (hereinafter together referred to as 'Cipla') in the U.S. District Court for ....
Regulatory Filings
2020-07-20 English
The Operations and Administrative Committee of the Company on 16th July, 2020 has allotted 37,102 equity shares of Rs.2/- each pursuant to exercise of the stock options by the option grantees ....
Regulatory Filings
2020-07-16 English
ESOP/ESOS/ESPS
Share Issue/Capital Change Classification · 95% confidence The document is a notification about the allotment of equity shares under the Employee Stock Option Scheme (ESOP) of the company Cipla Limited. It mentions the increase in issued share capital due to the allotment of shares. The document is addressed to stock exchanges and regulatory bodies, referencing compliance with SEBI Listing Obligations and Disclosure Requirements. The content is an update on share capital changes due to ESOP exercise, which fits the category of announcements related to share capital changes or new share issues. The document length is short (1983 characters) and it is not a full financial report or earnings release. Therefore, it is best classified as a Share Issue/Capital Change announcement.
2020-07-16 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.